S Osanto

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. doi request reprint Tasquinimod: a novel drug in advanced prostate cancer
    Susanne Osanto
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Future Oncol 9:1271-81. 2013
  2. pmc Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing
    Susanne Osanto
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    PLoS ONE 7:e38298. 2012
  3. doi request reprint Pre-analytical and analytical issues in the analysis of blood microparticles
    Yuana Yuana
    Department of Clinical Oncology, Leiden University Medical Centre, Leiden, The Netherlands
    Thromb Haemost 105:396-408. 2011

Collaborators

Detail Information

Publications5

  1. doi request reprint Tasquinimod: a novel drug in advanced prostate cancer
    Susanne Osanto
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Future Oncol 9:1271-81. 2013
    ..If the Phase II data are validated in the Phase III trial a new compound with a unique mode of action might become approved as a future therapy for minimally symptomatic mCRPC patients. ..
  2. pmc Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing
    Susanne Osanto
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    PLoS ONE 7:e38298. 2012
    ..Individual differentially expressed miRNAs may potentially serve as diagnostic or prognostic markers or future therapeutic targets in ccRCC. The biological relevance of candidate novel miRNAs is unknown at present...
  3. doi request reprint Pre-analytical and analytical issues in the analysis of blood microparticles
    Yuana Yuana
    Department of Clinical Oncology, Leiden University Medical Centre, Leiden, The Netherlands
    Thromb Haemost 105:396-408. 2011
    ..Ultimately, standardisation of pre-analytical procedures and the introduction of reliable and rapid methods for the measurement of MPs are urgently needed to facilitate their use as biomarker in the pathophysiology of diseases...